Ampio Pharmaceuticals Inc (AMPE)
0.33
+0.08
(+31.47%)
USD |
OTCM |
May 01, 15:59
Ampio Pharmaceuticals Cash and Short Term Investments (Quarterly): 4.089M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.089M |
| September 30, 2023 | 6.398M |
| June 30, 2023 | 6.953M |
| March 31, 2023 | 10.35M |
| December 31, 2022 | 12.65M |
| September 30, 2022 | 16.95M |
| June 30, 2022 | 22.89M |
| March 31, 2022 | 28.84M |
| December 31, 2021 | 33.89M |
| September 30, 2021 | 17.12M |
| June 30, 2021 | 20.55M |
| March 31, 2021 | 15.80M |
| December 31, 2020 | 17.35M |
| September 30, 2020 | 9.361M |
| June 30, 2020 | 4.842M |
| March 31, 2020 | 2.415M |
| December 31, 2019 | 6.532M |
| September 30, 2019 | 8.044M |
| June 30, 2019 | 12.78M |
| March 31, 2019 | 5.160M |
| December 31, 2018 | 7.585M |
| September 30, 2018 | 8.672M |
| June 30, 2018 | 4.662M |
| March 31, 2018 | 7.521M |
| December 31, 2017 | 8.209M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.828M |
| June 30, 2017 | 5.000M |
| March 31, 2017 | 2.348M |
| December 31, 2016 | 5.018M |
| September 30, 2016 | 7.750M |
| June 30, 2016 | 6.721M |
| March 31, 2016 | 11.11M |
| December 31, 2015 | 16.00M |
| September 30, 2015 | 35.38M |
| June 30, 2015 | 36.78M |
| March 31, 2015 | 43.27M |
| December 31, 2014 | 50.32M |
| September 30, 2014 | 56.83M |
| June 30, 2014 | 65.64M |
| March 31, 2014 | 78.23M |
| December 31, 2013 | 26.31M |
| September 30, 2013 | 32.07M |
| June 30, 2013 | 12.46M |
| March 31, 2013 | 16.53M |
| December 31, 2012 | 17.68M |
| September 30, 2012 | 20.27M |
| June 30, 2012 | 6.804M |
| March 31, 2012 | 8.292M |
| December 31, 2011 | 11.36M |
| September 30, 2011 | 6.994M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.415M
Minimum
Mar 2020
33.89M
Maximum
Dec 2021
13.57M
Average
12.65M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | 12.57M |
| Tivic Health Systems Inc | 3.395M |
| Oragenics Inc | 3.484M |
| Actinium Pharmaceuticals Inc | 76.68M |
| MAIA Biotechnology Inc | 7.151M |